Glenmede Trust’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,000
Closed -$872 3205
2019
Q3
$872 Hold
9,000
﹤0.01% 763
2019
Q2
$921 Hold
9,000
﹤0.01% 765
2019
Q1
$1.02K Buy
9,000
+8,894
+8,391% +$1.01K ﹤0.01% 740
2018
Q4
$4 Sell
106
-12,608
-99% -$476 ﹤0.01% 2631
2018
Q3
$693K Hold
12,714
﹤0.01% 823
2018
Q2
$1.05M Buy
12,714
+1,864
+17% +$154K ﹤0.01% 697
2018
Q1
$557K Hold
10,850
﹤0.01% 898
2017
Q4
$557K Buy
10,850
+1,456
+15% +$74.7K ﹤0.01% 898
2017
Q3
$837K Buy
9,394
+1,092
+13% +$97.3K ﹤0.01% 797
2017
Q2
$442K Hold
8,302
﹤0.01% 969
2017
Q1
$442K Hold
8,302
﹤0.01% 969
2016
Q4
$414K Hold
8,302
﹤0.01% 990
2016
Q3
$498K Buy
8,302
+3,302
+66% +$198K ﹤0.01% 935
2016
Q2
$255K Hold
5,000
﹤0.01% 1123
2016
Q1
$147K Hold
5,000
﹤0.01% 1239
2015
Q4
$226K Hold
5,000
﹤0.01% 1150
2015
Q3
$208K Buy
+5,000
New +$208K ﹤0.01% 1164